Chris Jackson (oncologist)

Last updated

Chris Jackson
Professor Chris Jackson, University of Otago (cropped).jpg
Jackson in 2023
Born
Christopher Glyn Charles Alexander Jackson

Oamaru, New Zealand
Alma mater University of Otago
Spouse Rachel Brooking
Medical career
Institutions
Research

Christopher Glyn Charles Alexander Jackson is a New Zealand medical oncologist specialising in gastrointestinal cancers and melanoma. He is professor of oncology at the University of Otago, and consultant oncologist at Dunedin Hospital. Jackson is the founder of Mercy Cancer Care, and co-leader of the Cancer National Clinical Network for Health New Zealand Te Whatu Ora. His advocacy led to the creation of the national cancer agency Te Aho o Te Kahu, and he serves on its advisory council. He is the former medical director of the Cancer Society of New Zealand.

Contents

Early life and education

Jackson was born and grew up in Oamaru, and is from a family of teachers, although he decided as a teenager that he wanted to become a doctor. [1] He attended Waitaki Boys' High School and then studied medicine at the University of Otago, graduating with Bachelor of Medicine and Bachelor of Surgery degrees in 2000. [1] After graduating, Jackson became interested in palliative care. [1]

Career

Jackson is a medical oncologist, specialising in gastrointestinal cancer, and melanoma. [1] He trained in New Zealand and then for two years at the Royal Marsden Hospital in London, and is now a consultant medical oncologist at Dunedin Hospital. [1] [2] Jackson became a Fellow of the Royal Australasian College of Physicians in 2008. [2] Jackson was promoted to full professor at the University of Otago in 2022, and was appointed deputy dean of the Dunedin School of Medicine in 2025. [3] [4]

Jackson co-founded Mercy Cancer Care at Mercy Hospital in Dunedin in 2011, as a unit providing specialist oncology across the lower South Island. [2] [1]

Jackson researches and writes on health and cancer policy and health services. He published an editorial for the British Medical Journal on the effects of cancer reforms in the United Kingdom. [5] His research on bowel cancer treatment variations in New Zealand led to the development of national standards in cancer care and a cancer quality improvement plan. [6] Jackson's involvement in an international research project revealed worse cancer outcomes in New Zealand, leading to a national conversation on cancer care and drug availability. [6] Jackson is also involved in research developing a new oral chemotherapy tablet. [6]

In 2015, Jackson was appointed medical director of the Cancer Society of New Zealand. [1] [7] During his tenure, Jackson appeared on news and current affairs programmes discussing the "post-code lottery" of cancer care and New Zealand's poor performance in cancer care compared to Australia. [8] [9] [10] [11] [6] Jackson called for Pharmac to establish an early-access scheme for medicines for cancer patients, [1] [12] [13] and was instrumental in obtaining new drugs for melanoma patients, in particular the immunotherapy drug pembrolizumab (also known as Keytruda). [14] Alongside Diana Sarfati and cancer patient Blair Vining, Jackson ran a campaign for a national cancer agency, which resulted in the publication of a ten-year Cancer Action Plan, and the establishment of national cancer agency Te Aho o Te Kahu in 2019 to enact that plan. [15] [16] [17] Jackson stepped down from his role in the Cancer Society in 2021 when his wife was elected as an MP. [6]

Jackson was chair of the South Island Bowel Cancer and the Colorectal Cancer Tumour Standards working groups, and is a member of the National Bowel Cancer Work group. [1] [7] He is on the executive committee of the New Zealand Society of Oncology. [15] In 2024, he was also appointed as inaugural co-lead for cancer on Health New Zealand's National Clinical Network, which works to improve access to cancer services across the country. [18]

Internationally, Jackson was elected to the board of the Union for International Cancer Control (UICC) in 2024, to serve a two-year term. [19] [18] [20] He served on the Asia Pacific Regional Council of the American Society of Clinical Oncology. [19] He is on the programme board for the International Cancer Benchmarking Project, which compares cancer survival statistics internationally. [15] He is also a founding member of Common Sense Oncology, a global movement initiated in Canada in 2023 which aims to "ensure patients have access to cancer treatments that provide meaningful improvements in outcomes that matter irrespective of where they live or their health system". [21]

Jackson is on the editorial board of the Journal of Global Oncology. [22]

Personal life

Jackson is married to Rachel Brooking, who was elected a Labour list MP in 2020 general election and MP for Dunedin in 2023. They have three children. [23]

Selected works

References

  1. 1 2 3 4 5 6 7 8 9 Kenny, Lee (1 September 2018). "National Portrait: For Chris Jackson, patients are his passion". Stuff . Retrieved 9 September 2025.
  2. 1 2 3 "Professor Christopher Jackson". Mercy Hospital. Retrieved 9 September 2025.
  3. "University promotes 39 to professor". Otago Daily Times . 17 December 2022. Retrieved 12 September 2025.
  4. "List of Heads of Departments (HODs)". University of Otago . 22 June 2023. Retrieved 12 September 2025.
  5. Diana Sarfati; Christopher Jackson (14 March 2018). "Cancer inequalities endure despite NHS reforms". The BMJ . 360: k989. doi:10.1136/BMJ.K989. ISSN   0959-8138. PMID   29540364. Wikidata   Q52655553.
  6. 1 2 3 4 5 De Lore, Clare (4 September 2021). "Their suffering compels me". New Zealand Listener . Retrieved 9 September 2025.
  7. 1 2 "New role for oncologist". Otago Daily Times . 24 August 2015. Retrieved 12 September 2025.
  8. "National cancer agency's 'unacceptable' 'post code lottery'". Bowel Cancer NZ. Retrieved 12 September 2025.
  9. Duff, Michelle (23 July 2017). "Cancer treatment has become a 'postcode lottery', say campaigners". Stuff . Retrieved 12 September 2025.
  10. Emma Russell (1 February 2019). "Calls for national cancer agency to put a stop to 'unacceptable' 'post code lottery'". The New Zealand Herald . Retrieved 12 September 2025.
  11. Cooke, Henry (23 July 2017). "Labour vows to end 'post-code lottery' of cancer care". Stuff . Retrieved 12 September 2025.
  12. "Cancer Society calling for life-saving drug". Newshub . Archived from the original on 10 February 2016. Retrieved 9 September 2025.
  13. Edwards, Bryce (3 March 2016). "Political roundup: Cancer drugs - the case for Keytruda". The New Zealand Herald . Retrieved 9 September 2025.
  14. Marwick, Felix; Smalley, Rachel (13 September 2025). "Cancer drug fight heads to parliament". NewstalkZB . Retrieved 12 September 2025.
  15. 1 2 3 "Leadership team". New Zealand Society for Oncology. Retrieved 9 September 2025.
  16. Michelle Mako; Jason Gurney; Moahia Goza; Myra Ruka; Nina Scott; Gary Thompson; Diana Sarfati (September 2022). "Te Aho o Te Kahu: weaving equity into national-level cancer control". Lancet Oncology Commission. 23 (9): e427 –e434. doi:10.1016/S1470-2045(22)00279-0. ISSN   1470-2045. Wikidata   Q136175057.
  17. Macandrew, Ruby (31 January 2019). "Cancer Society renews calls for a national cancer agency to replace DHB-led system". Stuff . Retrieved 9 September 2025.
  18. 1 2 "New appointments bolster Southern cancer services". Te Whatu Ora . 1 November 2024. Retrieved 9 September 2025.
  19. 1 2 "Board of Directors". UICC (Union for International Cancer Control). Retrieved 9 September 2025.
  20. "Sharing cancer knowledge globally brings benefits". University of Otago . 31 July 2025. Retrieved 9 September 2025.
  21. "About CSO – Common Sense Oncology" . Retrieved 12 September 2025.
  22. "Editorial Roster". JCO Global Oncology. Retrieved 12 September 2025.
  23. "New minister Rachel Brooking heeds mum's advice, wants to continue RMA reform". Stuff . 19 April 2023. Retrieved 9 September 2025.